Question 1

Does Bank of New York Mellon own SMMT stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Bank of New York Mellon holds 425,443 shares of SMMT (Summit Therapeutics), worth $7.2M.

Question 2

How many shares of SMMT does Bank of New York Mellon own?

Accepted Answer

As of its Q3 2026 13F, Bank of New York Mellon holds 425,443 shares of SMMT (Summit Therapeutics).

Question 3

What is Bank of New York Mellon's SMMT position worth?

Accepted Answer

As of its Q3 2026 13F, Bank of New York Mellon's SMMT position is worth $7.2M.

Question 4

Is Bank of New York Mellon buying or selling SMMT?

Accepted Answer

In Q3 2026, Bank of New York Mellon reduced its SMMT position by 5,856 shares (-1.4%).

Question 5

When did Bank of New York Mellon first buy SMMT?

Accepted Answer

Bank of New York Mellon first reported SMMT in its Q2 2021 13F and has listed it in 20 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	425,443	-1.4%	$7.2M	0.0%	$16.91	0
2026-Q2	Increased	431,299	+6.6%	$6.3M	0.0%	$14.57	29
2026-Q1	Increased	404,679	+14.4%	$7.7M	0.0%	$18.96	31
2025-Q4	Decreased	353,756	-3.6%	$6.2M	0.0%	$17.49	0
2025-Q3	Increased	367,126	+6.9%	$7.6M	0.0%	$20.66	29
2025-Q2	Increased	343,524	+0.8%	$7.3M	0.0%	$21.28	27
2025-Q1	Increased	340,775	+2.2%	$6.6M	0.0%	$19.29	28
2024-Q4	Increased	333,510	+33.7%	$6M	0.0%	$17.85	35
2024-Q3	Decreased	249,393	-11.1%	$5.5M	0.0%	$20.89	0